logo
Plus   Neg
Share
Email

Ford To Unveil Lincoln MKC Concept At 2013 North American Intl. Auto Show

Ford Motor Co. (F) said Sunday that it will debut the Lincoln MKC Concept at the 2013 North American International Auto Show. The Lincoln MKC Concept will be Lincoln's first-ever small vehicle.

Lincoln is the luxury automotive brand of Ford. The small luxury utility concept signals future Lincoln entry into the industry's fastest-growing segment.

Ford noted that with nearly 60 percent growth in 2012 and more than 200 percent in the last four years, the small luxury utility segment has far eclipsed all other luxury segments. According to the company, the opportunity is a key next step in Lincoln's strategy to grow with four all-new vehicles targeted at the highest-growth segments over the next four years.

Jim Farley, executive vice president of Global Marketing, Sales and Service and Lincoln said, "We are reinventing Lincoln by focusing on the largest and fastest-growing segments of the luxury market, while offering clients something different. The just-introduced MKZ re-establishes Lincoln in the largest luxury segment, and the MKC Concept highlights a key opportunity in the fastest-growing part of the luxury market."

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT